Table 2.
LD-GP therapy (n = 35) |
Others regimens (n = 23) |
P value | |
---|---|---|---|
Complete response | 0 (0.0) | 1 (4.3) | 0.220 |
Partial response | 9 (25.7) | 3 (13.0) | |
Stable disease | 22 (62.9) | 13 (56.5) | |
Progressive disease | 4 (11.4) | 6 (26.1) |
LD-GP low-dose combined therapy of gemcitabine and paclitaxel